Please login to the form below

Not currently logged in


This page shows the latest implant news and features for those working in and with pharma, biotech and healthcare.

2018 by Darwin

2018 by Darwin

It will punish, with extinction, those firms that either reject their implants or allow them to overpower routines, such as compliance, that are essential in our industry.

Latest news

More from news
Approximately 1 fully matching, plus 92 partially matching documents found.

Latest Intelligence

  • A unique ecosystem A unique ecosystem

    This enabled the launch of 27 innovative healthcare products. Examples include IRIMI, next-generation medical imaging services for hospitals; OsseoMatrix, a custom bone implant via direct 3D printing; and Biomodex, imaging

  • Tightening medical device safety Tightening medical device safety

    Building on the lessons learned from recent events (such as the French PIP breast implant scandal), the EU regulations require that each device bears a unique device identifier (UDI) and that ... In this regard, medical device users of implantable

  • Deal Watch - May 2017 Deal Watch - May 2017

    The acquisition provides Innocoll with the financial resources to continue the development of its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US

  • Here’s to all the bright sparks Here’s to all the bright sparks

    The first pacemaker implant took place just a few years later in 1958.

  • Deal Watch February 2017 Deal Watch February 2017

    In February, it granted North American rights to Zoladex, a goserelin acetate implant for prostate and breast cancer and benign gynaecological disorders, to US company TerSera Therapeutics. ... Licence. 358. AstraZeneca/ TerSera Therapeutics. Zoladex,

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Promimic appoints CEO Promimic appoints CEO

    Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development. ... Magnus brings valuable global leadership experience and a wide network from his time in the dental implant

  • Histogenics names former MedImmune president as CEO Histogenics names former MedImmune president as CEO

    This includes lead candidate NeoCart – a cartilage tissue implant in phase III trials. “

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The power of the patient

    Matt has spent much of his life struggling with the disease, yet he is now able to work as a photographer after having electrical implants fitted in his brain to control

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare through effective collaboration. Making work to feel proud of.

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...